GlassScriptPhysician profile
Amy L Howe
NPI 1699791327
$1,699.52
in general payments reported to CMS, 2019-2025
18 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.17 · 2023: $404 · 2024: $667 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $477.42 | 2024-2025 | |
| Lundbeck LLC | $433.58 | 2019-2025 | Vyepti, Rexulti |
| Tris Pharma INC | $185.55 | 2023-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Eisai INC. | $110.93 | 2023-2024 | |
| Pfizer INC. | $110.46 | 2023-2025 | |
| Grifols USA, LLC | $79.81 | 2023-2025 | Gamunex-C |
| Axsome Therapeutics, INC. | $48.17 | 2025 | Symbravo |
| Argenx US, INC. | $42.36 | 2023-2024 | Vyvgart Hytrulo, Vyvgart |
| Cala Health, INC. | $41.42 | 2024 | Cala Kiq, Cala Trio |
| Microtransponder, INC. | $24.18 | 2023 | |
| Sk Life Science, INC. | $23.34 | 2023 | |
| Alexion Pharmaceuticals, INC. | $21.84 | 2024 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $20.99 | 2025 | Rexulti |
| Abbott Laboratories | $18.04 | 2024 | Proclaim |
| Lilly USA, LLC | $17.76 | 2024 | Amyvid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $17.03 | 2024 | Exablate |
| Life Molecular Imaging LTD | $14.55 | 2025 | Neuraceq |
| Aucta Pharmaceuticals, INC. | $12.09 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.